ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,325Medicare Part D Prescriptions Filled, Including Refills

Rank: 141 out of 6969

$749K Total Retail Price of All Prescriptions

Rank: 247 out of 6969

600 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 600 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 13,946 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 1,651 1,512 1 1
AMLODIPINE BESYLATE 1,179 1,115 2 4
BENAZEPRIL HCL 980 913 10 3 18
OMEPRAZOLE 689 632 4 6
METFORMIN HCL 612 524 5 7
GLIMEPIRIDE 470 424 6 44
CRESTOR 433 415 7 39
ALENDRONATE SODIUM 398 375 8 14
LOSARTAN POTASSIUM 370 350 9 12
PROMETHAZINE HCL 351 321 R 10 203
FUROSEMIDE 323 313 11 10
ALLOPURINOL 301 292 12 35
LOSARTAN-HYDROCHLOROTHIAZIDE 281 274 13 53
LEVOTHYROXINE SODIUM 242 234 14 5
ZOLPIDEM TARTRATE 217 180 15 16
ACETAMINOPHEN-CODEINE 212 197 S3 16 73
CARVEDILOL 189 183 17 25
METFORMIN HCL ER 188 178 18 82
ZETIA 183 174 19 98
LISINOPRIL 181 144 20 2
SERTRALINE HCL 175 158 21 38
VYTORIN 173 154 22 148
METOPROLOL SUCCINATE 171 156 23 22
HYDROCODONE-ACETAMINOPHEN 139 131 S3 24 3
HYDROCHLOROTHIAZIDE 125 114 25 8
LANTUS SOLOSTAR 121 94 26 154
TAMSULOSIN HCL 118 109 27 23
GABAPENTIN 118 90 27 17
COLCRYS 113 99 29 211
DIOVAN HCT 107 107 30 57
IBUPROFEN 105 92 31 29
FINASTERIDE 99 96 32 80
SPIRIVA 98 90 33 66
DIOVAN 97 75 34 26
MICARDIS HCT 96 96 35 285
FLUOCINONIDE 92 86 36 134
METOPROLOL TARTRATE 92 89 36 13
ADVAIR DISKUS 86 75 38 45
LANTUS 86 63 38 50
SYMBICORT 86 86 38 149
JANUVIA 84 75 41 41
ATORVASTATIN CALCIUM 80 68 42 11
ACTOS 79 65 43 61
PANTOPRAZOLE SODIUM 79 74 43 31
FLUTICASONE PROPIONATE 77 77 45 24
MICARDIS 70 54 46 277
TRIAMCINOLONE ACETONIDE 68 61 47 55
NABUMETONE 68 50 47 209
FENOFIBRATE 68 68 47 63
PHENYTOIN SODIUM EXTENDED 67 47 50 169
PREDNISONE 63 62 51 70
POTASSIUM CHLORIDE 58 52 52 30
PRANDIN 58 47 52 271
DOXAZOSIN MESYLATE 55 49 54 74
LOVASTATIN 54 54 55 15
AZITHROMYCIN 53 47 56 42
CLOPIDOGREL 51 43 57 48
AMLODIPINE BESYLATE-BENAZEPRIL 50 49 58 91
ENALAPRIL MALEATE 50 50 58 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.